Claire Sackman
Biography
Overview
Claire Sackman is an associate in our global M&A and Corporate practice based in London.
She has experience in a broad range of corporate transactions, including public and private M&A, corporate restructurings and general corporate advisory.
Regularly working across multiple jurisdictions, she has advised clients across a range of industry sectors, including technology, real estate, infrastructure and healthcare.
Claire has also spent six months working in the Firm's Singapore office.
Experience
Representation of SoftBank Vision Fund II on its investment as lead investor in the Series C financing of TIER Mobility.
Representation of SPIE UK Limited (a subsidiary of the SPIE Group, the Euronext-listed independent European leader in multi-technical services in energy and communications) on the sale of its mobile maintenance activities to Rcapital Partners LLP
Representation of Intrum AB, the Swedish debt purchase and collection company, in the €328 million acquisition of an 80 percent stake in a joint venture with Piraeus Bank S.A. that will service a €28 billion portfolio of Piraeus' non-performing loans held in a securitization vehicle
Representation of Inflexion Private Equity Partners and its portfolio company Ocorian, provider of trustee administration and fiduciary services, on their leveraged buyout of Bridgepoint's portfolio Estera group of companies (a provider of trustee services)
Representation of FleetCor UK Acquisition Limited, in its acquisition of R2C Online Holdings Limited, a UK fleet management software and workshop management business
Representation of Rothschild as financial adviser to GeoPark Limited on its £242 million offer for Amerisur Resources Plc, full cycle independent oil exploration and production company
Representation of Standard Chartered Bank as financial adviser to PT Medco Energi Internasional Tbk on its £408.4 million offer for Ophir Energy plc, an oil and gas exploration and production company
Representation of Barclays Bank Plc as financial adviser to Boston Scientific Group on its £3.3 billion offer for BTG Plc, a global healthcare company
"A top firm. Really strong, they stand out from their competitor firms."
M&A: Upper mid-market and premium deals UK Legal 500 2020
